Quantimetrix leadership – industry experience, imagination, insight. Meet the team who continues to inspire our passion for innovation and helps push our thinking to the highest levels.
Monty Ban, Chairman, President and Chief Executive Officer
Thank you for making Quantimetrix an important part of your laboratory for over 40 years. We take the trust that you have placed in our products very seriously.
That’s why we design, develop and manufacture the finest liquid, laboratory quality controls. And we’re proud to do it all under one roof, in our Redondo Beach, California facility. We use the highest quality materials and manufacture all of our products in accordance with regulatory requirements. Our controls are crafted using a 200-step process. We pay meticulous attention to every detail to ensure that you get dependable results. We don’t take shortcuts. Our team has decades of experience, and we’re dedicated to improving the quality of patient care around the world.
We’ve been working hard on product enhancements that you will see in the coming months, and we’re looking forward to releasing several new products pending FDA clearance. Please enjoy our site and let us know what you think. We’d like to hear from you.
Kalyna Snylyk, Director of Regulatory Affairs and Quality Assurance
Regulatory compliance, or any FDA concerns, somehow Kalyna sees every detail and never misses one – always seeing the big picture. She just gets things done and keeps us compliant. Kalyna has 25 years of well-traveled experience overseeing four global sites for Regulatory Compliance and Quality Assurance within the healthcare, medical device and IVD industry providing us with a wealth of analytical wisdom.
Margie Segal, Creative Director, Marketing Communications
Margie joins the Quantimetrix family with more than 40 years of creative savvy honed at industry icons including Saul Bass & Associates, and Walt Disney. She brings branding and communications intelligence to the medical products industry. Her award-winning and whimsical work is well known throughout the industry and especially here at Quantimetrix.
Nehemias Muñiz, Director of Electrophoresis
Nehemias’ work with polyacrylamide gel electrophoresis and the analysis of lipoproteins at the National Heart, Lung and Blood Institute of the NIH, led to the development of Lipophor, a test method for the classification of hyperlipoproteinemia. Nemo came to Quantimetrix in 1986 and his work resulted in the development of Lipoprint, the only FDA cleared test for the separation and measurement of cholesterol in all lipoprotein fractions and subfractions in human serum or plasma.